193 related articles for article (PubMed ID: 16750479)
1. Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10.
Sharma SK; El Refaey H; Ebadi M
Brain Res Bull; 2006 Jun; 70(1):22-32. PubMed ID: 16750479
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.
Ebadi M; Brown-Borg H; El Refaey H; Singh BB; Garrett S; Shavali S; Sharma SK
Brain Res Mol Brain Res; 2005 Mar; 134(1):67-75. PubMed ID: 15790531
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
Abdin AA; Hamouda HE
Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
[TBL] [Abstract][Full Text] [Related]
4. Distribution kinetics of 18F-DOPA in weaver mutant mice.
Sharma SK; Ebadi M
Brain Res Mol Brain Res; 2005 Sep; 139(1):23-30. PubMed ID: 15979197
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 inhibits mitochondrial complex-1 down-regulation and nuclear factor-kappa B activation.
Ebadi M; Sharma SK; Wanpen S; Amornpan A
J Cell Mol Med; 2004; 8(2):213-22. PubMed ID: 15256069
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
Sharma SK; Ebadi M
Antioxid Redox Signal; 2003 Jun; 5(3):251-64. PubMed ID: 12880480
[TBL] [Abstract][Full Text] [Related]
7. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.
Matthews RT; Yang L; Browne S; Baik M; Beal MF
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8892-7. PubMed ID: 9671775
[TBL] [Abstract][Full Text] [Related]
8. Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease.
Ebadi M; Sharma S
Exp Biol Med (Maywood); 2006 Oct; 231(9):1576-83. PubMed ID: 17018883
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Yang L; Calingasan NY; Wille EJ; Cormier K; Smith K; Ferrante RJ; Beal MF
J Neurochem; 2009 Jun; 109(5):1427-39. PubMed ID: 19476553
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective actions of coenzyme Q10 in Parkinson's disease.
Sharma S; Kheradpezhou M; Shavali S; El Refaey H; Eken J; Hagen C; Ebadi M
Methods Enzymol; 2004; 382():488-509. PubMed ID: 15047119
[No Abstract] [Full Text] [Related]
11. Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons.
Kooncumchoo P; Sharma S; Porter J; Govitrapong P; Ebadi M
J Mol Neurosci; 2006; 28(2):125-41. PubMed ID: 16679553
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
Beal MF
J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
[TBL] [Abstract][Full Text] [Related]
13. WITHDRAWN: Coenzyme Q10 for Parkinson's disease.
Liu J; Wang LN; Zhan SY; Xia Y
Cochrane Database Syst Rev; 2012 May; 2012(5):CD008150. PubMed ID: 22592726
[TBL] [Abstract][Full Text] [Related]
14. Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson's disease rat model.
Park HW; Park CG; Park M; Lee SH; Park HR; Lim J; Paek SH; Choy YB
Sci Rep; 2020 Jun; 10(1):9572. PubMed ID: 32533070
[TBL] [Abstract][Full Text] [Related]
15. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10.
Klongpanichapak S; Govitrapong P; Sharma SK; Ebadi M
Neurochem Res; 2006 Mar; 31(3):303-11. PubMed ID: 16733807
[TBL] [Abstract][Full Text] [Related]
17. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases.
Beal MF; Matthews RT
Mol Aspects Med; 1997; 18 Suppl():S169-79. PubMed ID: 9266519
[TBL] [Abstract][Full Text] [Related]
18. Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10.
Somayajulu M; McCarthy S; Hung M; Sikorska M; Borowy-Borowski H; Pandey S
Neurobiol Dis; 2005 Apr; 18(3):618-27. PubMed ID: 15755687
[TBL] [Abstract][Full Text] [Related]
19. Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins.
Ebadi M; Sharma SK; Ghafourifar P; Brown-Borg H; El Refaey H
Methods Enzymol; 2005; 396():276-98. PubMed ID: 16291239
[TBL] [Abstract][Full Text] [Related]
20. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
Shults CW; Flint Beal M; Song D; Fontaine D
Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
